Sign in

CIK 0001664710

  • Non-accelerated filer
  • Smaller reporting company

Keros Therapeutics, Inc.

Sign in to watch
Ticker
KROS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
811173868
Phone
+1 617-314-6297
Business address
1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,619
in 1 filing, $6K under 10b5-1 plans

Net −$5,619. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Prener Anne −$6K Director sold 4% of stake
Date Insider Transaction Shares Price Value Owned after
2021-02-11 Lachey Jennifer Chief Scientific Officer Sale −1,460 $63.74 $93K 31,384
2021-02-11 Lachey Jennifer Chief Scientific Officer Sale −1,272 $64.93 $83K 30,112
2021-02-11 Lachey Jennifer Chief Scientific Officer Sale −1,845 $65.99 $122K 28,267
2021-02-11 Lachey Jennifer Chief Scientific Officer Sale −262 $67.05 $18K 28,005
2021-02-11 Lachey Jennifer Chief Scientific Officer Sale −14 $68.05 $953 27,991
2021-02-11 Lachey Jennifer Chief Scientific Officer Exercise or conversion · Employee Stock Option (right to buy) −5,300 145,605
2021-01-10 Regnante Keith Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +49,150 49,150
2021-01-10 Ordonez Claudia Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +42,250 42,250
2021-01-10 Lachey Jennifer Chief Scientific Officer Grant or award · Employee Stock Option (right to buy) +42,250 42,250
2021-01-10 Seehra Jasbir Chief Executive Officer Grant or award · Employee Stock Option (right to buy) +127,200 127,200
2020-12-17 GRAY MARY ANN Director Grant or award · Stock Option (right to buy) +16,587 16,587
2020-11-17 Nussbaum Ran Director Purchase +26,634 $50.00 $1.3M 2,288,151
2020-11-17 Nussbaum Ran Director Purchase +12,966 $50.00 $648K 1,122,768
2020-11-17 Nussbaum Ran Director Purchase +14,400 $50.00 $720K 1,228,326
2020-11-17 Nussbaum Ran Director Purchase +6,000 $50.00 $300K 155,262
2020-11-17 Kariv Tomer Director Purchase +26,634 $50.00 $1.3M 2,288,151
2020-11-17 Kariv Tomer Director Purchase +12,966 $50.00 $648K 1,122,768
2020-11-17 Kariv Tomer Director Purchase +14,400 $50.00 $720K 1,228,326
2020-11-17 Kariv Tomer Director Purchase +6,000 $50.00 $300K 155,262
2020-11-17 Pontifax Management 4 G.P. (2015) Ltd. 10% owner Purchase +26,634 $50.00 $1.3M 2,288,151

Page 29 of 36 · 707 trades